Research ArticleOriginal Article
Open Access

Clinicopathologic characteristics and outcomes of patients with mycosis fungoides

A single tertiary center retrospective analysis in Saudi Arabia

Faisal A. Alghubaywi, Sawsan A. Alharthi, Sarah S. Aldharman, Raneem H. Najjar, Majed Y. Aleissa, Ohoud Z. Aljarbou, Mohammed I. AlJasser and Mohammad A. Almohideb
Saudi Medical Journal April 2023, 44 (4) 394-400; DOI: https://doi.org/10.15537/smj.2023.44.4.20220860

References

  1. 1.↵
    1. Willemze R,
    2. Jaffe ES,
    3. Burg G,
    4. Cerroni L,
    5. Berti E,
    6. Swerdlow SH, et al.
    WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Sant M,
    2. Allemani C,
    3. Tereanu C,
    4. De Angelis R,
    5. Capocaccia R,
    6. Visser O, et al.
    Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116: 3724–3734. Erratum in: Blood 2011 Mar 24;117: 3477.
    OpenUrl
  3. 3.↵
    1. Lessin SR.
    Alibert lymphoma: renaming mycosis fungoides. Arch Dermatol 2009; 145: 209–210.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Muñoz-González H,
    2. Molina-Ruiz AM,
    3. Requena L.
    Clinicopathologic variants of mycosis fungoides. Actas Dermosifiliogr 2017; 108: 192–208.
    OpenUrl
  5. 5.↵
    1. van Doorn R,
    2. Zoutman WH,
    3. Dijkman R,
    4. de Menezes RX,
    5. Commandeur S,
    6. Mulder AA, et al.
    Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 2005; 23: 3886–3896.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Sausville EA,
    2. Worsham GF,
    3. Matthews MJ,
    4. Makuch RW,
    5. Fischmann AB,
    6. Schechter GP, et al.
    Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Human Pathol 1985; 16: 1098–1109.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Olsen E,
    2. Vonderheid E,
    3. Pimpinelli N,
    4. Willemze R,
    5. Kim Y,
    6. Knobler R, et al.
    Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713–22. Epub 2007 May 31. Erratum in: Blood 2008; 111: 4830.
    OpenUrl
  8. 8.↵
    1. van Doorn R,
    2. Van Haselen CW,
    3. van Voorst Vader PC,
    4. Geerts ML,
    5. Heule F,
    6. de Rie M, et al.
    Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000; 136: 504–510.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Luo Y,
    2. Liu Z,
    3. Liu J,
    4. Liu Y,
    5. Zhang W,
    6. Zhang Y.
    Mycosis Fungoides and Variants of Mycosis Fungoides: A retrospective study of 93 patients in a Chinese population at a single center. Ann Dermatol 2020; 32: 14–20.
    OpenUrl
  10. 10.↵
    1. AlGhamdi KM,
    2. Arafah MM,
    3. Al-Mubarak LA,
    4. Khachemoune A,
    5. Al-Saif FM.
    Profile of mycosis fungoides in 43 Saudi patients. Ann Saudi Med 2012; 32: 283–287.
    OpenUrlPubMedWeb of Science
  11. 11.↵
    1. Binamer Y.
    Cutaneous T-cell lymphoma in Saudi Arabia: retrospective single-center review. Ann Saudi Med 2017; 37: 212–215.
    OpenUrl
  12. 12.↵
    1. Kim YH,
    2. Liu HL,
    3. Mraz-Gernhard S,
    4. Varghese A,
    5. Hoppe RT.
    Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003; 139: 857–866.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Moon IJ,
    2. Lee KH,
    3. Choi JW,
    4. Lee WJ,
    5. Won CH,
    6. Chang S, et al.
    Clinical characteristics and long-term outcomes of 97 Korean patients with mycosis fungoides. Int J Dermatol 2021; 60: 1510–1519.
    OpenUrl
  14. 14.↵
    1. Dummer R,
    2. Kamarashev J,
    3. Kempf W,
    4. Haffner AC,
    5. Hess-Schmid M,
    6. Burg G.
    Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol 2002;138: 199–203.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.
    1. Massone C,
    2. Crisman G,
    3. Kerl H,
    4. Cerroni L.
    The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality. Br J Dermatol 2008; 159: 881–886.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Robson A,
    2. Assaf C,
    3. Bagot M,
    4. Burg G,
    5. Calonje E,
    6. Castillo C, et al.
    Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology 2015; 67: 425–441.
    OpenUrl
  17. 17.↵
    1. Martinez-Escala ME,
    2. Kantor RW,
    3. Cices A,
    4. Zhou XA,
    5. Kaplan JB,
    6. Pro B, et al.
    CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder. J Am Acad Dermatol 2017; 77: 489–496.
    OpenUrl
  18. 18.↵
    1. Nikolaou V,
    2. Papadavid E,
    3. Katsambas A,
    4. Stratigos A,
    5. Marinos L,
    6. Anagnostou D, et al.
    Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients. Br J Dermatol 2009; 161: 826–830.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Diamandidou E,
    2. Colome-Grimmer M,
    3. Fayad L,
    4. Duvic M,
    5. Kurzrock R.
    Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood 1998; 92: 1150–1159.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Salhany KE,
    2. Cousar JB,
    3. Greer JP, et al.
    Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988; 132: 265–277.
    OpenUrlPubMedWeb of Science
  21. 21.↵
    1. Talpur R,
    2. Sui D,
    3. Gangar P,
    4. Dabaja BS,
    5. Duvic M.
    Retrospective analysis of prognostic factors in 187 cases of transformed mycosis fungoides. Clin Lymphoma Myeloma Leuk 2016; 16: 49–56.
    OpenUrl
  22. 22.↵
    1. Agar NS,
    2. Wedgeworth E,
    3. Crichton S, et al.
    Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28: 4730–479.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Greer JP,
    2. Salhany KE,
    3. Cousar JB, et al.
    Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol 1990; 8: 215–227.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Barberio E,
    2. Thomas L,
    3. Skowron F,
    4. Balme B,
    5. Dalle S.
    Transformed mycosis fungoides: clinicopathological features and outcome. Br J Dermatol 2007; 157: 284–289.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Diamandidou E,
    2. Colome M,
    3. Fayad L,
    4. Duvic M,
    5. Kurzrock R.
    Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 1999; 40: 914–924.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords